FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904391185> ?p ?o ?g. }

• W2904391185 endingPage "254" @default.
• W2904391185 startingPage "247" @default.
• W2904391185 abstract "Objective: Patients with myelodysplastic syndromes (MDS), aplastic anemia (AA) or other rare anemia require chronic blood transfusions which can lead to iron overload and subsequent excess iron-mediated complications. Intensive iron chelation with deferasirox could remove excess iron and can alleviate these events; however, the long-term safety and efficacy in Chinese population are not clearly characterized. This study examined the long-term efficacy and safety of deferasirox in a real-world setting in Taiwan.Methods: This observational, non-interventional, single-arm, multi-center, phase IV study was designed to collect the safety and clinical information about patients who were treated with deferasirox according to investigator’s judgment and in accordance with the general clinical practice.Results: From 2009 to 2011, patients with MDS (N = 38), AA (N = 23), and other rare anemias (N = 18) were enrolled. The mean deferasirox exposure was 17.7 ± 4.02 mg/kg/day. The most common drug-related AEs were skin disorders (32.9%) and gastrointestinal disorders (30.4%), while grade 3–4 AEs were rare (5.1%). In the overall patient population, deferasirox effectively decreased serum ferritin levels at 1 year (P = 0.0154) and 3 years (P = 0.0424) from the baseline. Upon the use of deferasirox, 32.9% patients showed erythroid response and 16.7% patients had platelet response.Conclusions: For patients with MDS, AA, and other rare anemias, the AEs observed in this 3-year surveillance study with deferasirox were mostly mild or moderate. In addition, the hematological response rate was higher than that in the EPIC study, which primarily enrolled Caucasian patients." @default.
• W2904391185 created "2018-12-22" @default.
• W2904391185 creator A5014386297 @default.
• W2904391185 creator A5028706470 @default.
• W2904391185 creator A5039440415 @default.
• W2904391185 creator A5041872254 @default.
• W2904391185 creator A5048846949 @default.
• W2904391185 creator A5058608094 @default.
• W2904391185 creator A5058795431 @default.
• W2904391185 creator A5060666695 @default.
• W2904391185 creator A5083532124 @default.
• W2904391185 creator A5084631637 @default.
• W2904391185 creator A5089325904 @default.
• W2904391185 date "2018-12-17" @default.
• W2904391185 modified "2023-09-27" @default.
• W2904391185 title "Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan" @default.
• W2904391185 cites W1510055678 @default.
• W2904391185 cites W1995295757 @default.
• W2904391185 cites W1995812599 @default.
• W2904391185 cites W2005746290 @default.
• W2904391185 cites W2012426906 @default.
• W2904391185 cites W2023640756 @default.
• W2904391185 cites W2034674816 @default.
• W2904391185 cites W2054269881 @default.
• W2904391185 cites W2086820492 @default.
• W2904391185 cites W2100714797 @default.
• W2904391185 cites W2119692077 @default.
• W2904391185 cites W2144600743 @default.
• W2904391185 cites W2144826632 @default.
• W2904391185 cites W2157872347 @default.
• W2904391185 cites W2337170605 @default.
• W2904391185 cites W4360894011 @default.
• W2904391185 doi "https://doi.org/10.1080/16078454.2018.1557860" @default.
• W2904391185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30558522" @default.
• W2904391185 hasPublicationYear "2018" @default.
• W2904391185 type Work @default.
• W2904391185 sameAs 2904391185 @default.
• W2904391185 citedByCount "6" @default.
• W2904391185 countsByYear W29043911852020 @default.
• W2904391185 countsByYear W29043911852022 @default.
• W2904391185 crossrefType "journal-article" @default.
• W2904391185 hasAuthorship W2904391185A5014386297 @default.
• W2904391185 hasAuthorship W2904391185A5028706470 @default.
• W2904391185 hasAuthorship W2904391185A5039440415 @default.
• W2904391185 hasAuthorship W2904391185A5041872254 @default.
• W2904391185 hasAuthorship W2904391185A5048846949 @default.
• W2904391185 hasAuthorship W2904391185A5058608094 @default.
• W2904391185 hasAuthorship W2904391185A5058795431 @default.
• W2904391185 hasAuthorship W2904391185A5060666695 @default.
• W2904391185 hasAuthorship W2904391185A5083532124 @default.
• W2904391185 hasAuthorship W2904391185A5084631637 @default.
• W2904391185 hasAuthorship W2904391185A5089325904 @default.
• W2904391185 hasBestOaLocation W29043911851 @default.
• W2904391185 hasConcept C126322002 @default.
• W2904391185 hasConcept C187212893 @default.
• W2904391185 hasConcept C197934379 @default.
• W2904391185 hasConcept C2777799968 @default.
• W2904391185 hasConcept C2778248108 @default.
• W2904391185 hasConcept C2780007613 @default.
• W2904391185 hasConcept C2780817109 @default.
• W2904391185 hasConcept C2781053155 @default.
• W2904391185 hasConcept C2781440808 @default.
• W2904391185 hasConcept C2908647359 @default.
• W2904391185 hasConcept C71924100 @default.
• W2904391185 hasConcept C90924648 @default.
• W2904391185 hasConcept C99454951 @default.
• W2904391185 hasConceptScore W2904391185C126322002 @default.
• W2904391185 hasConceptScore W2904391185C187212893 @default.
• W2904391185 hasConceptScore W2904391185C197934379 @default.
• W2904391185 hasConceptScore W2904391185C2777799968 @default.
• W2904391185 hasConceptScore W2904391185C2778248108 @default.
• W2904391185 hasConceptScore W2904391185C2780007613 @default.
• W2904391185 hasConceptScore W2904391185C2780817109 @default.
• W2904391185 hasConceptScore W2904391185C2781053155 @default.
• W2904391185 hasConceptScore W2904391185C2781440808 @default.
• W2904391185 hasConceptScore W2904391185C2908647359 @default.
• W2904391185 hasConceptScore W2904391185C71924100 @default.
• W2904391185 hasConceptScore W2904391185C90924648 @default.
• W2904391185 hasConceptScore W2904391185C99454951 @default.
• W2904391185 hasIssue "1" @default.
• W2904391185 hasLocation W29043911851 @default.
• W2904391185 hasLocation W29043911852 @default.
• W2904391185 hasOpenAccess W2904391185 @default.
• W2904391185 hasPrimaryLocation W29043911851 @default.
• W2904391185 hasRelatedWork W1510055678 @default.
• W2904391185 hasRelatedWork W2024338366 @default.
• W2904391185 hasRelatedWork W2116016358 @default.
• W2904391185 hasRelatedWork W2320817941 @default.
• W2904391185 hasRelatedWork W2409957712 @default.
• W2904391185 hasRelatedWork W2561085805 @default.
• W2904391185 hasRelatedWork W2583222795 @default.
• W2904391185 hasRelatedWork W2904391185 @default.
• W2904391185 hasRelatedWork W3213405148 @default.
• W2904391185 hasRelatedWork W4249752330 @default.
• W2904391185 hasVolume "24" @default.
• W2904391185 isParatext "false" @default.
• W2904391185 isRetracted "false" @default.
• W2904391185 magId "2904391185" @default.

• next